Mohammad Rahmati-Yamchi (Mohammad Rahmati)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Cell Cycle Arrest

Binding Protein

Acute Lymphoblastic Leukemia

Top Venues

Advanced pharmaceutical bulletin

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Asiyeh Jebelli, Mohammad Khalaj-Kondori, Mohammad Rahmati-Yamchi
The Effect of Beta-Boswellic Acid on the Expression of Camk4 and Camk2α Genes in the PC12 Cell Line. Advanced pharmaceutical bulletin 10 (3) (2020)
Shirafkan Kordi, Mohammad Rahmati-Yamchi, Mehdi Asghari Vostakolaei, Abolfazl Barzegari, Jalal Abdolalizadeh
Purification of a Novel Anti-VEGFR2 Single Chain Antibody Fragment and Evaluation of Binding Affinity by Surface Plasmon Resonance. Advanced pharmaceutical bulletin 9 (1) (2019)
Elahe Naderali, Behnaz Valipour, Amir Afshin Khaki, Jafar Soleymani Rad, Alireza Alihemmati, Mohammad Rahmati-Yamchi, Hojjatollah Nozad Charoudeh
Positive Effects of PI3K/Akt Signaling Inhibition on PTEN and P53 in Prevention of Acute Lymphoblastic Leukemia Tumor Cells. Advanced pharmaceutical bulletin 9 (3) (2019)
Elahe Naderali, Amir Afshin Khaki, Jafar Soleymani Rad, Alireza Alihemmati, Mohammad Rahmati-Yamchi, Hojjatollah Nozad Charoudeh
Regulation and modulation of PTEN activity. Molecular biology reports 45 (6) (2018)